420 related articles for article (PubMed ID: 32575381)
1. Exploring the Therapeutic Potential of Membrane Transport Proteins: Focus on Cancer and Chemoresistance.
Almasi S; El Hiani Y
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575381
[TBL] [Abstract][Full Text] [Related]
2. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
3. The role of membrane transporters in ovarian cancer chemoresistance and prognosis.
Cerovska E; Elsnerova K; Vaclavikova R; Soucek P
Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):741-753. PubMed ID: 28511565
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of calcium homeostasis in cancer and its role in chemoresistance.
Kumari N; Pullaguri N; Rath SN; Bajaj A; Sahu V; Ealla KKR
Cancer Drug Resist; 2024; 7():11. PubMed ID: 38510751
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
6. Ion homeostasis, channels, and transporters: an update on cellular mechanisms.
Dubyak GR
Adv Physiol Educ; 2004 Dec; 28(1-4):143-54. PubMed ID: 15545343
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
8. Marine metabolites overcoming or circumventing multidrug resistance mediated by ATP-dependent transporters: a new hope for patient with tumors resistant to conventional chemotherapy.
Barthomeuf C; Bourguet-Kondracki ML; Kornprobst JM
Anticancer Agents Med Chem; 2008 Dec; 8(8):886-903. PubMed ID: 19075571
[TBL] [Abstract][Full Text] [Related]
9. Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.
Huang Y; Sadée W
Cancer Lett; 2006 Aug; 239(2):168-82. PubMed ID: 16169662
[TBL] [Abstract][Full Text] [Related]
10. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
11. What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.
Briz O; Perez-Silva L; Al-Abdulla R; Abete L; Reviejo M; Romero MR; Marin JJG
Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):577-593. PubMed ID: 31185182
[No Abstract] [Full Text] [Related]
12. Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca
Huang HK; Lin YH; Chang HA; Lai YS; Chen YC; Huang SC; Chou CY; Chiu WT
J Biomed Sci; 2020 Feb; 27(1):36. PubMed ID: 32079527
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.
Bai X; Chen Y; Hou X; Huang M; Jin J
Drug Metab Rev; 2016 Nov; 48(4):541-567. PubMed ID: 27320238
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms for tumour resistance to chemotherapy.
Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
[TBL] [Abstract][Full Text] [Related]
15. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
[TBL] [Abstract][Full Text] [Related]
16. Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.
Liu JJ; Lu J; McKeage MJ
Curr Cancer Drug Targets; 2012 Oct; 12(8):962-86. PubMed ID: 22794121
[TBL] [Abstract][Full Text] [Related]
17. Twist1 and Snail link Hedgehog signaling to tumor-initiating cell-like properties and acquired chemoresistance independently of ABC transporters.
Kong Y; Peng Y; Liu Y; Xin H; Zhan X; Tan W
Stem Cells; 2015 Apr; 33(4):1063-74. PubMed ID: 25588661
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer.
Morisaki T; Katano M
Curr Med Chem; 2003 Dec; 10(23):2517-21. PubMed ID: 14529467
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of efflux pumps that confer resistance to drugs.
Borges-Walmsley MI; McKeegan KS; Walmsley AR
Biochem J; 2003 Dec; 376(Pt 2):313-38. PubMed ID: 13678421
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
